224 related articles for article (PubMed ID: 30318841)
1. Interferon-induced transmembrane protein 1-mediated EGFR/SOX2 signaling axis is essential for progression of non-small cell lung cancer.
Yang YG; Koh YW; Sari IN; Jun N; Lee S; Phi LTH; Kim KS; Wijaya YT; Lee SH; Baek MJ; Jeong D; Kwon HY
Int J Cancer; 2019 Apr; 144(8):2020-2032. PubMed ID: 30318841
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of IFITM1 expression and correlation with microvessel density and epithelial-mesenchymal transition signature in lung adenocarcinoma.
Koh YW; Han JH; Jeong D; Kim CJ
Pathol Res Pract; 2019 Jul; 215(7):152444. PubMed ID: 31079850
[TBL] [Abstract][Full Text] [Related]
3. EGFR/Src/Akt signaling modulates Sox2 expression and self-renewal of stem-like side-population cells in non-small cell lung cancer.
Singh S; Trevino J; Bora-Singhal N; Coppola D; Haura E; Altiok S; Chellappan SP
Mol Cancer; 2012 Sep; 11():73. PubMed ID: 23009336
[TBL] [Abstract][Full Text] [Related]
4. Leukocyte Cell-Derived Chemotaxin 2 Retards Non-Small Cell Lung Cancer Progression Through Antagonizing MET and EGFR Activities.
Hung WY; Chang JH; Cheng Y; Chen CK; Chen JQ; Hua KT; Cheng CW; Hsiao M; Chung CL; Lee WJ; Chien MH
Cell Physiol Biochem; 2018; 51(1):337-355. PubMed ID: 30453282
[TBL] [Abstract][Full Text] [Related]
5. Repression of TIF1γ by SOX2 promotes TGF-β-induced epithelial-mesenchymal transition in non-small-cell lung cancer.
Wang L; Yang H; Lei Z; Zhao J; Chen Y; Chen P; Li C; Zeng Y; Liu Z; Liu X; Zhang HT
Oncogene; 2016 Feb; 35(7):867-77. PubMed ID: 25961934
[TBL] [Abstract][Full Text] [Related]
6. Plakophilin-2 accelerates cell proliferation and migration through activating EGFR signaling in lung adenocarcinoma.
Hao XL; Tian Z; Han F; Chen JP; Gao LY; Liu JY
Pathol Res Pract; 2019 Jul; 215(7):152438. PubMed ID: 31126818
[TBL] [Abstract][Full Text] [Related]
7. Interferon regulatory factor 4 (IRF4) is overexpressed in human non‑small cell lung cancer (NSCLC) and activates the Notch signaling pathway.
Qian Y; Du Z; Xing Y; Zhou T; Chen T; Shi M
Mol Med Rep; 2017 Nov; 16(5):6034-6040. PubMed ID: 28849037
[TBL] [Abstract][Full Text] [Related]
8. IFITM1 suppression blocks proliferation and invasion of aromatase inhibitor-resistant breast cancer in vivo by JAK/STAT-mediated induction of p21.
Lui AJ; Geanes ES; Ogony J; Behbod F; Marquess J; Valdez K; Jewell W; Tawfik O; Lewis-Wambi J
Cancer Lett; 2017 Jul; 399():29-43. PubMed ID: 28411130
[TBL] [Abstract][Full Text] [Related]
9. Gli1-Mediated Regulation of Sox2 Facilitates Self-Renewal of Stem-Like Cells and Confers Resistance to EGFR Inhibitors in Non-Small Cell Lung Cancer.
Bora-Singhal N; Perumal D; Nguyen J; Chellappan S
Neoplasia; 2015 Jul; 17(7):538-51. PubMed ID: 26297432
[TBL] [Abstract][Full Text] [Related]
10. Interferon-induced transmembrane protein 1 (IFITM1) is required for the progression of colorectal cancer.
Sari IN; Yang YG; Phi LT; Kim H; Baek MJ; Jeong D; Kwon HY
Oncotarget; 2016 Dec; 7(52):86039-86050. PubMed ID: 27852071
[TBL] [Abstract][Full Text] [Related]
11. Low-Dose Nicotine Activates EGFR Signaling via α5-nAChR and Promotes Lung Adenocarcinoma Progression.
Wang ML; Hsu YF; Liu CH; Kuo YL; Chen YC; Yeh YC; Ho HL; Wu YC; Chou TY; Wu CW
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32957649
[TBL] [Abstract][Full Text] [Related]
12. NFATc2 enhances tumor-initiating phenotypes through the NFATc2/SOX2/ALDH axis in lung adenocarcinoma.
Xiao ZJ; Liu J; Wang SQ; Zhu Y; Gao XY; Tin VP; Qin J; Wang JW; Wong MP
Elife; 2017 Jul; 6():. PubMed ID: 28737489
[TBL] [Abstract][Full Text] [Related]
13. Nestin regulates proliferation, migration, invasion and stemness of lung adenocarcinoma.
Narita K; Matsuda Y; Seike M; Naito Z; Gemma A; Ishiwata T
Int J Oncol; 2014 Apr; 44(4):1118-30. PubMed ID: 24481417
[TBL] [Abstract][Full Text] [Related]
14. Reciprocal Negative Regulation between EGFR and DEPTOR Plays an Important Role in the Progression of Lung Adenocarcinoma.
Zhou X; Guo J; Ji Y; Pan G; Liu T; Zhu H; Zhao J
Mol Cancer Res; 2016 May; 14(5):448-57. PubMed ID: 26896556
[TBL] [Abstract][Full Text] [Related]
15. Scutellariabarbata D. Don extraction selectively targets stemness-prone NSCLC cells by attenuating SOX2/SMO/GLI1 network loop.
Chen WW; Gong KK; Yang LJ; Dai JJ; Zhang Q; Wang F; Li XL; Xi SC; Du J
J Ethnopharmacol; 2021 Jan; 265():113295. PubMed ID: 32841701
[TBL] [Abstract][Full Text] [Related]
16. Elevated expression of BIRC6 protein in non-small-cell lung cancers is associated with cancer recurrence and chemoresistance.
Dong X; Lin D; Low C; Vucic EA; English JC; Yee J; Murray N; Lam WL; Ling V; Lam S; Gout PW; Wang Y
J Thorac Oncol; 2013 Feb; 8(2):161-70. PubMed ID: 23287853
[TBL] [Abstract][Full Text] [Related]
17. Impact of the integrin signaling adaptor protein NEDD9 on prognosis and metastatic behavior of human lung cancer.
Kondo S; Iwata S; Yamada T; Inoue Y; Ichihara H; Kichikawa Y; Katayose T; Souta-Kuribara A; Yamazaki H; Hosono O; Kawasaki H; Tanaka H; Hayashi Y; Sakamoto M; Kamiya K; Dang NH; Morimoto C
Clin Cancer Res; 2012 Nov; 18(22):6326-38. PubMed ID: 23037767
[TBL] [Abstract][Full Text] [Related]
18. ETS-1 Induces Endothelial-Like Differentiation and Promotes Metastasis in Non-Small Cell Lung Cancer.
Zhou X; Zhou R; Zhou H; Li Q; Hong J; Meng R; Zhu F; Zhang S; Dai X; Peng G; Wu G; Li Z
Cell Physiol Biochem; 2018; 45(5):1827-1839. PubMed ID: 29510376
[TBL] [Abstract][Full Text] [Related]
19. CHAF1B promotes proliferation and reduces apoptosis in 95‑D lung cancer cells and predicts a poor prognosis in non‑small cell lung cancer.
Duan Y; Liu T; Li S; Huang M; Li X; Zhao H; Li J
Oncol Rep; 2019 Apr; 41(4):2518-2528. PubMed ID: 30720130
[TBL] [Abstract][Full Text] [Related]
20. NDRG1/Cap43/Drg-1 may predict tumor angiogenesis and poor outcome in patients with lung cancer.
Azuma K; Kawahara A; Hattori S; Taira T; Tsurutani J; Watari K; Shibata T; Murakami Y; Takamori S; Ono M; Izumi H; Kage M; Yanagawa T; Nakagawa K; Hoshino T; Kuwano M
J Thorac Oncol; 2012 May; 7(5):779-89. PubMed ID: 22481237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
